Synaptonemal complex protein 3 as a novel prognostic marker in early stage non-small cell lung cancer

Human Pathology

Volumn 44, Issue 4, 2013, Pages 472-479

  Chung, Joon Yong ^a   Kitano, Haruhisa ^a,b   Takikita, Mikiko ^a,b   Cho, Hanbyoul ^a,c   Noh, Kyung Hee ^d   Kim, Tae Woo ^d   Ylaya, Kris ^a   Hanaoka, Jun ^b   Fukuoka, Junya ^e   Hewitt, Stephen M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c Yonsei University College of Medicine   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e TOYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Immunohistochemistry; Non small cell lung cancer; Prognostic marker; Synaptonemal complex protein 3; Tissue microarray

Indexed keywords

DNA BINDING PROTEIN; SYNAPTONEMAL COMPLEX PROTEIN 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CYTOPLASM; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NUCLEAR PROTEINS; PLEURA; PNEUMONECTOMY; PROGNOSIS; SURVIVAL RATE; SYNAPTONEMAL COMPLEX; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84875231299     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.06.018     Document Type: Article

References (25)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. E.S. Kim, V. Hirsh, and T. Mok Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial Lancet 372 2008 1809 1818
3. W.C. Cho Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer Biomed Pharmacother 61 2007 515 519
4. S.H. Heo, S.J. Lee, H.M. Ryoo, J.Y. Park, and J.Y. Cho Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS Proteomics 7 2007 4292 4302
5. H.J. Sung, and J.Y. Cho Biomarkers for the lung cancer diagnosis and their advances in proteomics BMB Rep 41 2008 615 625
6. L. Yuan, J. Pelttari, and E. Brundell The synaptonemal complex protein SCP3 can form multistranded, cross-striated fibers in vivo J Cell Biol 142 1998 331 339
7. J. Pelttari, M.R. Hoja, and L. Yuan A meiotic chromosomal core consisting of cohesin complex proteins recruits DNA recombination proteins and promotes synapsis in the absence of an axial element in mammalian meiotic cells Mol Cell Biol 21 2001 5667 5677
8. T. Miyamoto, S. Hasuike, and L. Yogev Azoospermia in patients heterozygous for a mutation in SYCP3 Lancet 362 2003 1714 1719
9. P. Niemeyer, O. Tureci, T. Eberle, N. Graf, M. Pfreundschuh, and U. Sahin Expression of serologically identified tumor antigens in acute leukemias Leuk Res 27 2003 655 660
10. T.H. Kang, K.H. Noh, and J.H. Kim Ectopic expression of X-linked lymphocyte-regulated protein pM1 renders tumor cells resistant to antitumor immunity Cancer Res 70 2010 3062 3070
11. J. Fukuoka, T. Fujii, and J.H. Shih Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer Clin Cancer Res 10 2004 4314 4324
12. D.G. Pfister, D.H. Johnson, and C.G. Azzoli American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003 J Clin Oncol 22 2004 330 353
13. J. Kononen, L. Bubendorf, and A. Kallioniemi Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 1998 844 847
14. J.Z. Shou, N. Hu, and M. Takikita Overexpression of CDC25B and LAMC2 mRNA and protein in esophageal squamous cell carcinomas and premalignant lesions in subjects from a high-risk population in China Cancer Epidemiol Biomarkers Prev 17 2008 1424 1435
15. J.H. Lammers, M. van Aalderen, and A.H. Peters A change in the phosphorylation pattern of the 30000-33000 Mr synaptonemal complex proteins of the rat between early and mid-pachytene Chromosoma 104 1995 154 163
16. D. Choma, J.P. Daures, X. Quantin, and J.L. Pujol Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data Br J Cancer 85 2001 14 22
17. K.H. Noh, T.H. Kang, and J.H. Kim Activation of Akt as a mechanism for tumor immune evasion Mol Ther 17 2009 439 447
18. R.J. Botelho, L. DiNicolo, and N. Tsao The genomic structure of SYCP3, a meiosis-specific gene encoding a protein of the chromosome core Biochim Biophys Acta 1518 2001 294 299
19. W. Jiao, H.M. Lin, and J. Datta Aberrant nucleocytoplasmic localization of the retinoblastoma tumor suppressor protein in human cancer correlates with moderate/poor tumor differentiation Oncogene 27 2008 3156 3164
20. S.W. Blain, and J. Massague Breast cancer banishes p27 from nucleus Nat Med 8 2002 1076 1078
21. S.D. Boyd, K.Y. Tsai, and T. Jacks An intact HDM2 RING-finger domain is required for nuclear exclusion of p53 Nat Cell Biol 2 2000 563 568
22. B.R. Henderson Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover Nat Cell Biol 2 2000 653 660
23. G.J. Inman, F.J. Nicolas, and C.S. Hill Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity Mol Cell 10 2002 283 294
24. S.S. Yoo, J.E. Choi, and W.K. Lee Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer J Clin Oncol 27 2009 5823 5829
25. T. Dhillon, F.A. Mauri, and G. Bellezza Overexpression of the mammalian target of rapamycin: a novel biomarker for poor survival in resected early stage non-small cell lung cancer J Thorac Oncol 5 2010 314 319